Abstract
Surgical clinical trials have seldom used a “sham” or placebo surgical procedure as a control, owing to ethical concerns. Recently, several ethical commentators have argued that sham surgery is either inherently or presumptively unethical. In this article I contend that these arguments are mistaken, and that there are no sound ethical reasons for an absolute prohibition of sham surgery in clinical trials. Reflecting on three cases of sham surgery, especially on the recently reported results of a sham-controlled trial of arthroscopic surgery for arthritis of the knee, I present an ethical analysis that focuses on the methodological rationale for use of sham surgery, risk-benefit assessment, and informed consent.
Similar content being viewed by others
References
Moseley J.B., O’Malley K., Petersen N.J., et al. (2002) A controlled trial of arthroscopic surgery for osteoarthritis of the knee. New England Journal of Medicine 347: 81–88.
Frader J.E., Caniano D.A. (1998) Research and innovation in surgery. In: McCullough L.B., Jones J.W., Brody B.A., eds. Surgical Ethics. New York: Oxford University Press, 1998:.216–241.
Clark P.A. (2002) Placebo surgery for Parkinson’s diseases: do the benefits outweight the risks? Journal of Law, Medicine & Ethics 30: 58–68.
London A.J., Kadane J.B. (2002) Placebos that harm: sham surgery controls in clinical trials. Statistical Methods in Medical Research 11: 413–427.
Miller F.G., Brody H. (2002) What makes placebo-controlled trials unethical? American Journal of Bioethics 2(2): 3–9.
Horng S., Miller F.G. (2002) Is placebo surgery ethical? New England Journal of Medicine 347: 137–139.
Emanuel E.J., Wendler D., Grady C. (2000) What makes clinical research ethical? JAMA 283: 2701–2711.
Freeman T.B., Vawter D.E., Leaverton P.E., et al. (1999) Use of placebo surgery in controlled trials of a cellular-based therapy for Parkinson’s disease. New England Journal of Medicine 341: 988–991.
Macklin R. (199). The ethical problem with sham surgery in clinical research. New England Journal of Medicine 341: 992–996.
Dekkers W., Boer G.B. (2001) Sham neurosurgery in patients with Parkinson’s disease: is it morally acceptable? Journal of Medical Ethics 27: 151–156.
Gillett G.R. (2001) Unnecessary holes in the head. IRB 23(6): 1–6.
Weijer C. (2002) I need a placebo like I need a hole in the head. Journal of Law, Medicine & Ethics 30: 69–72.
Albin R.L. (2002) Sham surgery controls: intracerebral grafting of fetal tissue for Parkinson’s disease and proposed criteria for use of sham surgery controls. Journal of Medical Ethics 28:322–325.
Beecher H.K. (1961) Surgery as placebo. JAMA 176: 88–93.
Cobb L.A., Thomas G.I., Dillard D.H., et al. (1959) An evaluation of internal-mammary artery ligation by a double-blind technic. New England Journal of Medicine 260: 1115–1118.
Dimond E.G., Kittle C.G., Crockett J.E. (1960) Comparison of internal mammary artery ligation and sham operation for angina pectoris. American Journal of Cardiology 5: 484–486.
Advisory Committee on Human Radiation Experiments (1995) Final Report. Washington, D.C.: U.S. Government Printing Office: 130–170.
Freed C.R., Greene P.E., Breeze R.E., et al. (2001) Transplantation of embryonic dopamine neurons for severe Parkinson’s disease. New England Journal of Medicine 344: 710–719.
Moseley J.B., Wray N.P., Kuykendall D., et al. (1996) Arthroscopic treatment of osteoarthritis of the knee: a prospective, randomized, placebo-controlled trial. Results of a pilot study. American Journal of Sports Medicine 24: 28–34.
Wray (2002) personal communication.
Gerritsen A.A.M., de Vet H.C.W., Scholten B.J.P.M., et al. (2002) Splinting vs surgery in the treatment of carpal tunnel syndrome. JAMA 288: 1245–1251.
Lasagna L. (1955) The controlled clinical trial: theory and practice. Journal of Chronic Diseases: 353–367.
Ernst E., Resch K.L. (1995) Concept of true and perceived placebo effects. British Medical Journal 311: 551–553.
Hrobjartsson A., Gotzsche P.C. (2001) Is the placebo powerless? New England Journal of Medicine 344: 1594–1602.
Johnson A.G. (1994) Surgery as a placebo. Lancet 344: 1140–1142.
Kaptchuk T.J., Goldman P., Stone D.A., Stason W.B. (2000) Do medical devices have enhanced placebo effects? Journal of Clinical Epidemiology 53: 786–792.
Moerman D.E., Jonas W.B. (2002) Deconstructing the placebo effect and finding the meaning response. Annals of Internal Medicine 136: 471–476.
Department of Health and Human Services. Protection of Human Subjects. Code of Federal Regulations 45CFR46. 1991.
Author information
Authors and Affiliations
Corresponding author
Additional information
This paper is reprinted by permission of the American Journal of Bioethics and MIT Press Journals and appeared originally as follows: Franklin G. Miller, ‘Sham Surgery: An Ethical Analysis’, American Journal of Bioethics 3:4 (Fall, 2003), pp. 41–48. © 2003 by the Massachusetts Institute of Technology.
The opinions expressed are those of the author and do not necessarily reflect the position or policy of the National Institutes of Health, the Public Health Service, or the Department of Health and Human Services.
Rights and permissions
About this article
Cite this article
Miller, F.G. Sham surgery: An ethical analysis. SCI ENG ETHICS 10, 157–166 (2004). https://doi.org/10.1007/s11948-004-0073-x
Issue Date:
DOI: https://doi.org/10.1007/s11948-004-0073-x